Back

Clinical outcomes in patients with diabetes mellitus receiving dual antiplatelet therapy more than 12 months after second-generation drug eluting stent implantation

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Dual antiplatelet therapy: the long and the short of it! Thrombosis and platelets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Sung Woo Cho

Inje University Ilsan Paik hospital, Goyang (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
longer dual antiplatelet therapy beyond 9 months does not influence neointimal condition after second generation drug eluting stent implantation
Doctor Y. Goryo (Nara, JP)
Abstract Slides
Presentation thumbnail
Longer-term oral antiplatelet use in stable post-MI patients: Insights from the TIGRIS study
Doctor S. Goodman (Toronto, CA)
Abstract
Presentation thumbnail
Duration of dual antiplatelet therapy in patients treated with second generation drug-eluting stents: a systematic review and meta-analysis
Doctor M. Bianco (Orbassano, IT)
Abstract Slides
Presentation thumbnail
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation in patients with or without diabetes: a patient-level meta-analysis of randomised trials
Doctor G. Gargiulo (Napoly, IT)
Abstract Slides
Presentation thumbnail
Long term dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomised studies
Doctor G. Ferrante (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Dual antiplatelet therapy: the long and the short of it!

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources